Literature DB >> 28007064

The Society of Thoracic Surgeons Congenital Heart Surgery Database Public Reporting Initiative.

Jeffrey P Jacobs1.   

Abstract

Three basic principles provide the rationale for the Society of Thoracic Surgeons (STS) Congenital Heart Surgery Database (CHSD) public reporting initiative: (1) Variation in congenital and pediatric cardiac surgical outcomes exist. (2) Patients and their families have the right to know the outcomes of the treatments that they will receive. (3). It is our professional responsibility to share this information with them in a format they can understand. The STS CHSD public reporting initiative facilitates the voluntary transparent public reporting of congenital and pediatric cardiac surgical outcomes using the STS CHSD Mortality Risk Model. The STS CHSD Mortality Risk Model is used to calculate risk-adjusted operative mortality and adjusts for the following variables: age, primary procedure, weight (neonates and infants), prior cardiothoracic operations, non-cardiac congenital anatomic abnormalities, chromosomal abnormalities or syndromes, prematurity (neonates and infants), and preoperative factors (including preoperative/preprocedural mechanical circulatory support [intraaortic balloon pump, ventricular assist device, extracorporeal membrane oxygenation, or cardiopulmonary support], shock [persistent at time of surgery], mechanical ventilation to treat cardiorespiratory failure, renal failure requiring dialysis and/or renal dysfunction, preoperative neurological deficit, and other preoperative factors). Operative mortality is defined in all STS databases as (1) all deaths, regardless of cause, occurring during the hospitalization in which the operation was performed, even if after 30 days (including patients transferred to other acute care facilities); and (2) all deaths, regardless of cause, occurring after discharge from the hospital, but before the end of the 30th postoperative day. The STS CHSD Mortality Risk Model has good model fit and discrimination with an overall C statistics of 0.875 and 0.858 in the development sample and the validation sample, respectively. These C statistics are the highest C statistics ever seen in a pediatric cardiac surgical risk model. Therefore, the STS CHSD Mortality Risk Model provides excellent adjustment for case mix and should mitigate against risk aversive behavior. The STS CHSD Mortality Risk Model is the best available model to date for measuring outcomes after pediatric cardiac surgery. As of March 2016, 60% of participants in STS CHSD have agreed to publicly report their outcomes through the STS Public Reporting Online website (http://www.sts.org/quality-research-patient-safety/sts-public-reporting-online). Although several opportunities exist to improve our risk models, the current STS CHSD public reporting initiative provides the tools to report publicly, and with meaning and accuracy, the outcomes of congenital and pediatric cardiac surgery.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28007064     DOI: 10.1053/j.pcsu.2016.09.008

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu        ISSN: 1092-9126


  6 in total

1.  Characterization of "ICU-30": A Binary Composite Outcome for Neonates With Critical Congenital Heart Disease.

Authors:  Monique M Gardner; Garrett Keim; Jill Hsia; Anh D Mai; J William Gaynor; Andrew C Glatz; Nadir Yehya
Journal:  J Am Heart Assoc       Date:  2022-06-14       Impact factor: 6.106

2.  Effect of Trisomy 21 on Postoperative Length of Stay and Non-cardiac Surgery After Complete Repair of Tetralogy of Fallot.

Authors:  Eric T Purifoy; Beverly J Spray; Joe S Riley; Parthak Prodhan; Elijah H Bolin
Journal:  Pediatr Cardiol       Date:  2019-09-07       Impact factor: 1.655

3.  Health Care Policy and Congenital Heart Disease: 2020 Focus on Our 2030 Future.

Authors:  Devyani Chowdhury; Jonathan N Johnson; Carissa M Baker-Smith; Robert D B Jaquiss; Arjun K Mahendran; Valerie Curren; Aarti Bhat; Angira Patel; Audrey C Marshall; Stephanie Fuller; Bradley S Marino; Christina M Fink; Keila N Lopez; Lowell H Frank; Mishaal Ather; Natalie Torentinos; Olivia Kranz; Vivian Thorne; Ryan R Davies; Stuart Berger; Christopher Snyder; Arwa Saidi; Kenneth Shaffer
Journal:  J Am Heart Assoc       Date:  2021-10-08       Impact factor: 5.501

4.  Syndromic and Non-Syndromic Patients with Repaired Tetralogy of Fallot: Does It Affect the Long-Term Outcome?

Authors:  Giulio Calcagni; Camilla Calvieri; Anwar Baban; Francesco Bianco; Rosaria Barracano; Massimo Caputo; Andrea Madrigali; Stefani Silva Kikina; Marco Alfonso Perrone; Maria Cristina Digilio; Marco Pozzi; Aurelio Secinaro; Berardo Sarubbi; Lorenzo Galletti; Maria Giulia Gagliardi; Andrea de Zorzi; Fabrizio Drago; Benedetta Leonardi
Journal:  J Clin Med       Date:  2022-02-06       Impact factor: 4.964

5.  Predictors of major adverse events and complications after ventricular septal defects surgical closure in children less than 10 kg.

Authors:  Ayman R Abdelrehim; Mustafa Al-Muhaya; Alassal A Alkodami; Luna S Baangood; Mansour Al-Mutairi; Abdul Quadeer; Fath A Alabsi; M Alashwal; Mohamed Mofeed F Morsy; Abdulhameed A Alnajjar; Sherif S Salem
Journal:  J Cardiothorac Surg       Date:  2022-09-07       Impact factor: 1.522

6.  Prognostic Model to Predict Postoperative Adverse Events in Pediatric Patients With Aortic Coarctation.

Authors:  Yan Gu; Qianqian Li; Rui Lin; Wenxi Jiang; Xue Wang; Gengxu Zhou; Junwu Su; Xiangming Fan; Pei Gao; Mei Jin; Yuan Wang; Jie Du
Journal:  Front Cardiovasc Med       Date:  2021-05-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.